Skip to main content
Science Advances logoLink to Science Advances
. 2021 Sep 8;7(37):eabg2293. doi: 10.1126/sciadv.abg2293

Mitigation of Pseudomonas syringae virulence by signal inactivation

Simon Sieber 1,, Anugraha Mathew 2,, Christian Jenul 2, Tobias Kohler 1, Max Bär 1, Víctor J Carrión 3, Francisco M Cazorla 4, Urs Stalder 1, Ya-Chu Hsieh 1, Laurent Bigler 1, Leo Eberl 2,*, Karl Gademann 1,*
PMCID: PMC8442906  PMID: 34516871

Chemical inactivation of a volatile signal is a novel approach to attenuate the virulence of a devastating plant pathogen.

Abstract

Pseudomonas syringae is an important plant pathogen of many valuable crops worldwide, with more than 60 identified pathovars. The phytotoxins produced by these organisms were related to the severity of the damage caused to the plant. An emerging strategy to treat bacterial infections relies on interference with their signaling systems. In this study, we investigated P. syringae pv. syringae, which produces the virulence factor mangotoxin that causes bacterial apical necrosis on mango leaves. A previously unknown signaling molecule named leudiazen was identified, determined to be unstable and volatile, and responsible for mangotoxin production. A strategy using potassium permanganate, compatible with organic farming, was developed to degrade leudiazen and thus to attenuate the pathogenicity of P. syringae pv. syringae.

INTRODUCTION

Pseudomonas represent an excellent example of both benign and pathogenic plant-bacteria interactions (1). While some strains are beneficial for plants (2), others, such as members of the genus Pseudomonas syringae (P. syringae), are important pathogens, which infect almost all economically important crop species (3). Decades of studies have revealed the broad repertoire of virulence strategies used by P. syringae, which include large numbers of functionally redundant type III secretion system (T3SS) effectors and phytotoxins (4). A toxin that has a crucial ecological impact is mangotoxin (5), which is produced by P. syringae pv. syringae (Pss) and identified as the causal agent of bacterial apical necrosis (BAN) of mango trees (6). While the structure of the toxin remains unknown, the mbo gene cluster encoding mangotoxin biosynthesis genes was first described in Pss (7) and was later also identified in many other P. syringae pathovars (8, 9).

Investigations of the regulation of mangotoxin production has led to the identification of the mgo operon (mgoBCAD), which was shown to be required for the production of an unknown signaling molecule (Fig. 1A) (10, 11). The mgo gene cluster comprises four genes including a nonribosomal peptide synthetase (NRPS) complex (MgoA), and homolog clusters have been identified in other strains, such as Pseudomonas entomophila (pvf cluster) (12), Pseudomonas aurantiaca PB-St2 (13), Pseudomonas sp. SH-C52 (14, 15), several Pseudomonas fluorescens (16, 17), and various Burkholderia species (ham cluster) (18, 19). Recently, we found that the ham cluster directs the synthesis of the diazeniumdiolate valdiazen (1), which was identified as a signal molecule that positively autoregulates its own expression (18). Furthermore, in 2018, Morgan et al. investigated the substrate specificity of the NRPS domain of MgoA and its homologs PvfC and HamD and concluded that the different strains produce at least two distinct signaling molecules (20). A comparison of the mgo, pvf, and ham clusters (Fig. 1) reveals that the four genes required for the biosynthesis of the signals are highly conserved in P. syringae, Pseudomonas entomophila, and Burkholderia cenocepacia, respectively (tables S1 to S4). Here, we demonstrate that mangotoxin production is controlled by leudiazen (2, Fig. 1B), a new member of the diazeniumdiolate family of bacterial signal molecules. Furthermore, we speculated that the knowledge of the signaling molecule structure might pave the way to develop a strategy for plant protection.

Fig. 1. Mitigation of plant pathogenicity.

Fig. 1.

(A) P. syringae plant pathogens represent a global problem as for Pss, which is responsible for BAN caused by the virulence factor mangotoxin that is regulated by an unknown signal (6, 10, 11). (B) Discovery of leudiazen (2) as the unknown signal and developing a mitigation strategy compatible with organic farming procedures. Photo Credit: Anugraha Mathew, University of Zurich.

RESULTS

Given the homology of the NRPS complexes MgoA and HamD (fig. S1), we speculated that the mgo signal could be a related diazeniumdiolate compound. We used a transcriptional fusion of the promoter of the mangotoxin gene cluster (mbo) to the lacZ gene in a Pss ΔmgoA mutant background (ΔmgoA) to detect the signal-inducing mangotoxin production. The biosensor was activated by the wild-type extract but not by the ΔmgoA extract (fig. S2). Valdiazen (1) only weakly induced the biosensor relative to the Pss extract, suggesting that the unknown signaling molecule may not be valdiazen (fig. S2). Bioassay-guided fractionation under various conditions did not result in a pure product, as bioactivity was lost during the purification procedure, suggesting that the signal is either unstable or volatile.

In a complementary approach, we synthesized various derivatives of 1 and tested them for activation of the mbo promoter with the underlying anticipation that the indigenous signal shows the highest bioactivity. The choice of the derivatives was guided by a bioinformatic analysis of the predicted specificity of the MgoA NRPS (fig. S1 and table S5) (20). On this basis, we selected the aliphatic amino acids glycine, alanine, leucine, and isoleucine as starting material. Leudiazen (2) and isoleudiazen (3) were synthesized using a four-step procedure, and glydiazen (4) and aladiazen (5) [also known as nitrosofungin (21)] were synthesized using an alternative route because of the instability of the intermediates (5, Fig. 2A). The five derivatives were tested, and leudiazen (2) was found to be the most potent inducer of the mbo promoter (Fig. 2B). No differences in the activities of the (R) and (S) enantiomer of leudiazen were observed (fig. S3). Using a targeted ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS) approach (163 to 83 Da), we found 74 ± 7 nM leudiazen (2) in the Pss extract (fig. S4). No leudiazen (2) was detected in the extract of the ΔmgoA mutant (Fig. 2C).

Fig. 2. Leudiazen: A novel signal.

Fig. 2.

(A) Valdiazen derivatives that have been designed, synthesized, and tested. (B) Activity of the PmboA-lacZ fusion in the presence of different valdiazen derivatives. Error bars represent the SEM, and statistical analysis was performed using one-way analysis of variance (ANOVA) and Tukey’s multiple comparisons as posttest; ns, not significant (P > 0.05), n = 3 (**P < 0.01 and ***P < 0.001). (C) Leudiazen (2) detection by UHPLC-MS/MS in the SRM mode. From top to bottom: Pss extract, ΔmgoA mutant extract, and synthetic leudiazen ((S)-2).

The biosensor was activated in a dose-dependent manner and 10 μM leudiazen ((S)-2), where the β-galactosidase activity was higher than the level observed for Pss::PmboA-lacZ (Fig. 3A and fig. S5). Leudiazen’s (2) ability to trigger mangotoxin production was evaluated using an Escherichia coli (E. coli) indicator strain. The antimicrobial activity, which indicates mangotoxin production, of the ΔmgoA mutant was restored to the level of the wild-type strain by the addition of 10 μM leudiazen ((S)-2) but not below this concentration (Fig. 3B and fig. S6). Likewise, 10 μM leudiazen ((S)-2) was needed to rescue the virulence of the mutant strain to the level of the wild-type in a tomato leaflet infection model (Fig. 3C).

Fig. 3. Positive regulation of mangotoxin by leudiazen.

Fig. 3.

(A) Activities of the mboA promoter in the presence of leudiazen (2). Error bars represent the SEM, and statistical analysis was performed using one-way ANOVA and Tukey’s multiple comparisons as posttest. ns, not significant (P > 0.05), n = 3 (***P < 0.001). (B) Mangotoxin production assay using E. coli JM 105 as an indicator. The halos, indicating mangotoxin production, are highlighted with a dashed line. (C) Tomato leaves were infected with Pss and the ΔmgoA mutant in the absence or presence of 10 μM leudiazen ((S)-2). Pictures were taken after 5 and 10 days postinfection (dpi). Photo Credit: Anugraha Mathew, University of Zurich.

Preliminary results suggested that leudiazen (2) could easily evaporate and be present in the gas phase (figs. S7 to S9). To confirm the volatility of 2, we performed a split plate assay, where one compartment contained the E. coli JM 105 (DSM 3949) reporter strain overlaid with the ΔmgoA mutant strain while the other compartment contained 20 μM leudiazen (2, Fig. 4A). After incubation for 24 hours, a halo was observed around the ΔmgoA mutant strain, suggesting mangotoxin production by the mbo gene cluster. In a control experiment, in which charcoal was added to a third compartment of the petri dish, growth of the E. coli JM 105 indicator strain was not inhibited, suggesting that leudiazen (2) present in the gas phase was adsorbed by the charcoal (fig. S10). Furthermore, the degradation of leudiazen (2) was studied by nuclear magnetic resonance spectroscopy, and the results indicated that the stability of 2 is solvent dependent (figs. S11 and S12).

Fig. 4. Volatile signal and novel treatment of BAN disease.

Fig. 4.

(A) Split plate assay with leudiazen (2) into two compartments and Δmgo stabbed on two spots over the lawn of E. coli JM 105 (DSM 3949) in the third compartment. Halos denote growth inhibition due to mangotoxin production. (B) Leudiazen [((S)-2), 10 μg/ml] solution treated with KMnO4 solution at concentrations varying from 0 to 500 ppm. UV, ultraviolet. (C) Tomato leaves infected with Pss and analyzed after 5 or 10 dpi and either treated with KMnO4 solution or left untreated. (D) Amount of P. syringae cells recovered from infected plants at 10 dpi. Error bars represent the SEM, and the statistical analysis was performed using a t test; ns, not significant (P > 0.05). Photo Credit: Anugraha Mathew, University of Zurich.

We hypothesized that the mgo signaling system’s inhibition could be an effective way to control Pss pathogenicity. A chemical strategy was developed for leudiazen (2) degradation and potentially other diazeniumdiolates. In agreement with previous work reporting that KMnO4 efficiently decomposes the diazeniumdiolate functional group (22), we observed that leudiazen ((S)-2) was inactivated by treatment with 300 parts per million (ppm) of KMnO4 within 10 min (Fig. 4B and fig. S13). Spraying of infected tomato leaves with an aqueous KMnO4 solution (1000 ppm) suppressed necrotic symptoms (Fig. 4C). We recovered Pss cells from the treated and the untreated leaves (Fig. 4D), indicating that the chemical treatment abolished toxin production and did not inhibit bacterial growth.

DISCUSSION

Our study adds leudiazen (2) as only the second member of the diazeniumdiolate signal family. Homologs of the leudiazen gene cluster are widespread among Pseudomonas strains (tables S1 to S4), indicating that the signal may regulate the production of diverse secondary metabolites in these organisms. While valdiazen (1) controls the production of an antifungal agent in the opportunistic human pathogen H111 (18), we show that leudiazen (2) controls mangotoxin production in the plant pathogen Pss. The biosynthesis and chemical properties of diazeniumdiolate natural products have been recently investigated in several studies (1820, 2326). A remarkable aspect of leudiazen in contrast with other diazeniumdiolates is its volatility and the ability to be transmitted through the air (Fig. 4A). Only very few volatile signals in bacteria have been described to date (2729), and only two of those were determined to control the virulence in important plant pathogens. Volatile signals may be advantageous for long-distance communication, a feature that may be important for bacteria that live on plant surfaces.

Interference with bacterial signaling has emerged as a valuable strategy for developing novel anti-infective drugs that do not aim at killing the pathogen but attenuate their virulence (30). Our data demonstrate that leudiazen (2) can be inactivated by treatment with a dilute KMnO4 solution without affecting the bacteria’s growth. A common strategy to interfere with bacterial communication is based on the enzymatic degradation of signaling molecules (31, 32). Here, we present the first example of a chemical approach to inactivate a bacterial signaling molecule to attenuate virulence. Notably, the concentration of the KMnO4 solution used in our experiments is regulatorily approved for use in organic farming within the European Union (33).

MATERIALS AND METHODS

Microbiological and analytical procedures

Strains and plasmids used in this study are listed in table S6. Pss wild-type UMAF0158, Pss ΔmgoA mutant as well as strains carrying transcriptional lacZ fusions, Pss pMP/PmboA-lacZ, and ΔmgoA pMP/PmboA-lacZ strains were provided by V.J.C. and F.M.C. The construction of both Pss ΔmgoA mutant and the transcriptional fusions has been reported previously (7, 10). E. coli strains were routinely grown in LB medium (BD Difco, USA) at 37°C, while P. syringae strains were grown at 30°C. For the extraction of leudiazen (2), as well as for promoter activity measurements, P. syringae strains were grown in Pseudomonas minimal salts (PMS) medium [consists of 1 g of (NH4)H2PO4 per liter, 0.2 g of KCl per liter, and 0.2 g of anhydrous MgSO4 per liter] (34). The pH was adjusted to 7.0 before autoclaving, and 0.2% glucose was added as a carbon source. Yeast extract (0.005%) was routinely added to the PMS medium to boost growth. When required, media were supplemented with antibiotics at the following concentrations: kanamycin (100 μg/ml), gentamicin (20 μg/ml), tetracycline (20 μg/ml), and chloramphenicol (20 μg/ml).

Assessment of promoter activity by β-galactosidase assay

Promoter activity of the transcriptional lacZ fusions in liquid cultures was assessed by β-galactosidase assays as described before with minor modifications (35). Briefly, bacterial cells were grown overnight in PMS medium. Where indicated, synthetic valdiazen (1) or leudiazen (2) or ((S)-2) or ((R)-2) and different valdiazen derivatives dissolved in methanol were added to the cultures. Fifty to 200 μl of cells were harvested and resuspended in Z buffer (1 ml), and OD600 (optical density at 600 nm) values were recorded. To permeabilize the cell membrane, chloroform (25 μl) and sodium dodecyl sulfate (SDS, 0.1%) were added to the residual bacterial suspension (1 ml), vortexed for 10 s, and incubated at 28°C for 10 min. The reaction was initiated by adding o-nitrophenyl-β-d-galactoside (200 μl) solution (4 mg/ml in Z buffer) to each sample, vortexed briefly, and incubated at room temperature (RT). The reaction was stopped by the addition of an aqueous Na2CO3 solution (500 μl, 1 M). The samples were centrifuged at 16,000 rpm for 10 min, and cell debris–free supernatant (1 ml) was used to measure the absorbance at 420 and 550 nm. The promoter activity (expressed as Miller units) was determined using the following formula: 1 Miller unit = 1000×OD4201.75×OD550t×v×OD600. Where t = reaction time in minutes and v = volume of assayed sample in milliliters. Data were based on three independent biological replicates (n  = 3). For every β-galactosidase assay, a sample containing only the growth medium was processed as described above and used as a blank.

Extraction procedure

Bacterial strains were grown in PMS medium containing 0.005% yeast extract for 7 days with agitation (220 rpm) at 30°C. Bacterial cultures were centrifuged for 10 min at 8000 rpm in a Sorvall RC-5C plus centrifuge at 4°C. Culture supernatants were subsequently filtered with a Millipore Express Plus 0.22-μm system to remove the cell debris. The cell-free supernatant was acidified to pH 5 with an aqueous HCl solution (10 M) and extracted thrice with 0.5 volumes of dichloromethane. The organic phases were combined, dried with MgSO4, filtered, and concentrated under reduced pressure to obtain the crude extract.

Method for the detection and quantification of leudiazen (2)

Leudiazen (2) was quantified by UHPLC–ESI (electrospray ionization)–MS/MS (Ultimate 3000 LC, Thermo Fisher Scientific; coupled to a TSQ Quantum Ultra, Thermo Fisher Scientific) using a Kinetex EVO C18 column (50 mm by 2.1 mm, 1.7 μm) at a flow rate of 0.4 ml/min. The solvent system was composed of A (H2O with 0.1% HCO2H) and B (MeCN with 0.1% HCO2H). After isocratic elution at 5% B for 1 min, the gradient varied from 5% to 60% of B in 2.5 min, 60 to 95% of B in 1 min, and 95 to 100% of B in 0.05 min, and the column was finally washed with 100% B for 1.24 min. The detection was achieved in the selected reaction monitoring (SRM) mode using the specific fragmentation of the protonated molecules [M + H]+ at mass/charge ratio (m/z) 163 into the fragment ion at m/z 83 Da at a collision energy of 14 eV. The quantification was done using a calibration curve obtained from analytical standard solutions prepared in MeOH at the following concentrations: 1, 5, 10, 20, 50, and 100 μg/ml. A sample volume of 3 μl was injected. Cultures of Pss (2 liters) and the Δmgo mutant (2 liters) were prepared following the extraction procedure described above. The crude extract was resuspended in MeOH (1 ml). A concentration of 24 ± 3 μg/ml of leudiazen (2) was determined in the Pss extract using a calibration curve (fig. S4), which represents a leudiazen (2) concentration of 74 ± 7 nM in the supernatant of Pss. Leudiazen (2) was not detected in the Δmgo crude extract.

Volatility experiment

A glass vial (2 ml) containing leudiazen [((S)-2), ~5 mg] was placed into a vacuum chamber at 0.02 mbar, and another sample was placed under a gentle flow of nitrogen at 40°C. The samples were weighted each 2 hours for 8 hours (fig. S7). The headspace experiment was performed by heating leudiazen [((S)-2), 0.9 mg] in a 10-ml vial for 10 min at 100°C (figs. S8 and S9). Then, 10 ml of the gas phase was transferred into another vial containing 1-ml acetonitrile with a gas-tight syringe. This vial was shaken for 30 s, and an aliquot of the acetonitrile layer (3 μl/min) was measured with ESI–high-resolution mass spectrometry (ESI-HRMS). ESI-HRMS: m/z 161.0930 (C6H13N2O3 [M − H]; calc. 161.0932, −1.2 ppm). A control experiment was performed by injecting a MeCN solution (fig. S9).

Mangotoxin production assay

Mangotoxin production was determined using an E. coli strain as an indicator using a previously described procedure (34) with minor modifications. Briefly, a double layer of the indicator microorganism, an E. coli K12 strain, was prepared, and after solidification, the Pss strains to be tested were stab-inoculated [Pss wild type, Δmgo mutant, and Δmgo mutant complemented with different amounts of leudiazen (2) or ((S)-2) or ((R)-2)] on to the agar seeded with E. coli. The plates were incubated at 30°C for 48 hours and observed for inhibition zones around the colony.

E. coli killing assay was also performed on split petri dishes to confirm the volatile-mediated effect of leudiazen. PMS medium mixed with E. coli [107 colony-forming unit (CFU) final concentration] was included in one compartment of the petri dish, and the ΔmgoA mutant was stab-inoculated on to it while 10 μl of 20 μM leudiazen was spotted in the adjacent compartments. A control plate, containing charcoal in a third compartment to trap the volatile leudiazen, was also included in the assay (fig. S10).

Virulence assay using tomato leaflets as model host

To assess whether the putative signal molecules restored the virulence in the mutant strain, detached tomato leaflets (Hellfrucht Frühstamm variety) were used as model hosts, and the virulence assay was performed as previously described (36) with some modifications. Exponentially growing cultures of Pss in PMS were adjusted to 108 CFU ml−1. In one set of virulence assay, 10-μl drops of the bacterial suspension were injected on three different points on one side of a leaflet, while three 10-μl drops of an aqueous MgSO4 solution (10 mM) were injected on the other side of the same leaflet as a control. Alternatively, in another set of virulence assay, six 10-μl drops of the bacterial suspension were injected on six different points on the same leaflet, and detached leaflets inoculated with an aqueous MgSO4 solution (10 mM) were included in all experiments as a control. Six tomato leaflets were used per strain, and the infected leaflets were maintained at 22°C and a 16:8-hour light:dark photoperiod for a period of 10 days. These experiments were repeated three times. The development and severity of necrosis on the leaflets were determined every 2 days for a period of 10 days. Bacterial strains were retrieved from the infected leaves, and colony counts were calculated on several days after inoculation.

KMnO4 treatment of tomato leaves infected with Pss

To test whether KMnO4 protects the tomato leaves from Pss infection, detached tomato leaves infected with Pss, as described above, were treated with an aqueous KMnO4 solution. Leaflets (6) infected with Pss were dipped in an aqueous KMnO4 solution (1000 ppm) with manual shaking at RT, allowing a total contact time of around 20 s. The solution was decanted, and the leaves were then dipped in fresh sterile distilled water to remove any traces of KMnO4. The tomato leaflets (6) infected with Pss without KMnO4 treatment were included in the assay. Both sets of leaflets were maintained for a period of 10 days, and development of necrotic symptoms was recorded. Bacterial strains were recovered from both sets of leaflets after 10 days, and presence of Pss was confirmed by polymerase chain reaction using Pss-specific primers.

Degradation procedures

Aqueous KMnO4 solution (500 μl at a concentration of 20, 200, 600, or 1000 ppm) were added to 500 μl of an aqueous solution of leudiazen [((S)-2), 10 μg/ml] to obtain solutions having a concentration of KMnO4 of 10, 100, 300, and 500 ppm. The samples were stirred at RT for 10 min, filtered, and 3 μl injected to the UHPLC-ultraviolet system (254 nm).

Acknowledgments

We thank K. Agnoli for help with the signal extraction procedures and C. Fabbri and M. Müller for the technical assistance. Funding: The research was funded, in part, by the Swiss National Science Foundation (CRSII5_186410 and 200021_182043). Author contributions: The study was designed by S.S., A.M., L.E., and K.G. Experiments were planned by S.S., A.M., L.E., and K.G. S.S., A.M., C.J., T.K., M.B., U.S., and Y.-C.H. performed experiments. S.S., A.M., C.J., T.K., M.B., V.J.C., F.M.C., U.S., Y.-C.H., L.B., L.E., and K.G. analyzed and discussed data. All authors contributed to the redaction of the manuscript. Competing interests: The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials.

Supplementary Materials

This PDF file includes:

Supplementary Materials and Methods

Figs. S1 to S13

Tables S1 to S6

References

REFERENCES AND NOTES

  • 1.Passera A., Compant S., Casati P., Maturo M. G., Battelli G., Quaglino F., Antonielli L., Salerno D., Brasca M., Toffolatti S. L., Mantegazza F., Delledonne M., Mitter B., Not just a pathogen? Description of a plant-beneficial Pseudomonas syringae strain. Front. Microbiol. 10, 1409 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pieterse C. M. J., Zamioudis C., Berendsen R. L., Weller D. M., Van Wees S. C. M., Bakker P. A. H. M., Induced systemic resistance by beneficial microbes. Annu. Rev. Phytopathol. 52, 347–375 (2014). [DOI] [PubMed] [Google Scholar]
  • 3.Lamichhane J. R., Messéan A., Morris C. E., Insights into epidemiology and control of diseases of annual plants caused by the Pseudomonas syringae species complex. J. Gen. Plant. Pathol. 81, 331–350 (2015). [Google Scholar]
  • 4.Xin X.-F., Kvitko B., He S. Y., Pseudomonas syringae: What it takes to be a pathogen. Nat. Rev. Microbiol. 16, 316–328 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Arrebola E., Cazorla F. M., Durán V. E., Rivera E., Olea F., Codina J. C., Pérez-García A., de Vicente A., Mangotoxin: A novel antimetabolite toxin produced by Pseudomonas syringae inhibiting ornithine/arginine biosynthesis. Physiol. Mol. Plant Pathol. 63, 117–127 (2003). [Google Scholar]
  • 6.Arrebola E., Cazorla F. M., Romero D., Pérez-García A., de Vicente A., A nonribosomal peptide synthetase gene (mgoA) of Pseudomonas syringae pv. syringae is involved in mangotoxin biosynthesis and is required for full virulence. Mol. Plant Microbe Interact. 20, 500–509 (2007). [DOI] [PubMed] [Google Scholar]
  • 7.Carrión V. J., Arrebola E., Cazorla F. M., Murillo J., de Vicente A., The mbo operon is specific and essential for biosynthesis of mangotoxin in Pseudomonas syringae. PLOS ONE 7, e36709 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sultanov R. I., Arapidi G. P., Vinogradova S. V., Govorun V. M., Luster D. G., Ignatov A. N., Comprehensive analysis of draft genomes of two closely related pseudomonas syringae phylogroup 2b strains infecting mono- and dicotyledon host plants. BMC Genomics 17, 1010 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Marcelletti S., Scortichini M., Comparative genomic analyses of multiple Pseudomonas strains infecting Corylus avellana trees reveal the occurrence of two genetic clusters with both common and distinctive virulence and fitness traits. PLOS ONE 10, e0131112 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Arrebola E., Carrión V. J., Cazorla F. M., Pérez-García A., Murillo J., de Vicente A., Characterisation of the mgo operon in Pseudomonas syringae pv. syringae UMAF0158 that is required for mangotoxin production. BMC Microbiol. 12, 10 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Carrión V. J., van der Voort M., Arrebola E., Gutiérrez-Barranquero J. A., de Vicente A., Raaijmakers J. M., Cazorla F. M., Mangotoxin production of Pseudomonas syringae pv. syringae is regulated by MgoA. BMC Microbiol. 14, 46 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Vallet-Gely I., Opota O., Boniface A., Novikov A., Lemaitre B., A secondary metabolite acting as a signalling molecule controls Pseudomonas entomophila virulence. Cell. Microbiol. 12, 1666–1679 (2010). [DOI] [PubMed] [Google Scholar]
  • 13.Mehnaz S., Bauer J. S., Gross H., Complete genome sequence of the sugar cane endophyte Pseudomonas aurantiaca PB-St2, a disease-suppressive bacterium with antifungal activity toward the plant pathogen Colletotrichum falcatum. Genome Announc. 2, e01108-13 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Van Der Voort M., Meijer H. J. G., Schmidt Y., Watrous J., Dekkers E., Mendes R., Dorrestein P. C., Gross H., Raaijmakers J. M., Genome mining and metabolic profiling of the rhizosphere bacterium Pseudomonas sp. SH-C52 for antimicrobial compounds. Front. Microbiol. 6, 693 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kirchner N., Cano-Prieto C., van der Voort M., Raaijmakers J. M., Gross H., Draft genome sequence of lipopeptide-producing strain Pseudomonas fluorescens DSM 11579 and comparative genomics with Pseudomonas sp. strain SH-C52, a closely related lipopeptide-producing strain. Microbiol. Resour. Announce. 9, e00304–20 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Loper J. E., Hassan K. A., Mavrodi D. V., Davis E. W. II, Lim C. K., Shaffer B. T., Elbourne L. D. H., Stockwell V. O., Hartney S. L., Breakwell K., Henkels M. D., Tetu S. G., Rangel L. I., Kidarsa T. A., Wilson N. L., van de Mortel J. E., Song C., Blumhagen R., Radune D., Hostetler J. B., Brinkac L. M., Durkin A. S., Kluepfel D. A., Wechter W. P., Anderson A. J., Kim Y. C., Pierson L. S. III, Pierson E. A., Lindow S. E., Kobayashi D. Y., Raaijmakers J. M., Weller D. M., Thomashow L. S., Allen A. E., Paulsen I. T., Comparative genomics of plant-associated Pseudomonas spp.: Insights into diversity and inheritance of traits involved in multitrophic interactions. PLOS Genet. 8, e1002784 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.De Vrieze M., Varadarajan A. R., Schneeberger K., Bailly A., Rohr R. P., Ahrens C. H., Weisskopf L., Linking comparative genomics of nine potato-associated Pseudomonas isolates with their differing biocontrol potential against late blight. Front. Microbiol. 11, 857 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Jenul C., Sieber S., Daeppen C., Mathew A., Lardi M., Pessi G., Hoepfner D., Neuburger M., Linden A., Gademann K., Eberl L., Biosynthesis of fragin is controlled by a novel quorum sensing signal. Nat. Commun. 9, 1297 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sieber S., Daeppen C., Jenul C., Mannancherril V., Eberl L., Gademann K., Biosynthesis and structure-activity relationship investigations of the diazeniumdiolate antifungal agent fragin. ChemBioChem 21, 1587–1592 (2020). [DOI] [PubMed] [Google Scholar]
  • 20.Morgan G. L., Kretsch A. M., Santa Maria K. C., Weeks S. J., Li B., Specificity of nonribosomal peptide synthetases in the biosynthesis of the Pseudomonas virulence factor. Biochemistry 58, 5249–5254 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dolak L. A., Castle T. M., Hannon B. R., Argoudelis A. D., Reusser F., Fermentation, isolation, characterization and structure of nitrosofungin. J. Antibiot. 36, 1425–1430 (1983). [DOI] [PubMed] [Google Scholar]
  • 22.Hrabie J. A., Keefer L. K., Chemistry of the nitric oxide-releasing diazeniumdiolate (“nitrosohydroxylamine”) functional group and its oxygen-substituted derivatives. Chem. Rev. 102, 1135–1154 (2002). [DOI] [PubMed] [Google Scholar]
  • 23.Hermenau R., Mehl J. L., Ishida K., Dose B., Pidot S. J., Stinear T. P., Hertweck C., Genomics-driven discovery of NO-donating diazeniumdiolate siderophores in diverse plant-associated bacteria. Angew. Chem. Int. Ed. 58, 13024–13029 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jiao J., Du J., Frediansyah A., Jahanshah G., Gross H., Structure elucidation and biosynthetic locus of trinickiabactin from the plant pathogenic bacterium Trinickia caryophylli. J. Antibiot. 73, 28–34 (2020). [DOI] [PubMed] [Google Scholar]
  • 25.Ng T. L., McCallum M. E., Zheng C. R., Wang J. X., Wu K. J. Y., Balskus E. P., The l-alanosine gene cluster encodes a pathway for diazeniumdiolate biosynthesis. ChemBioChem 21, 1155–1160 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wang M., Niikura H., He H.-Y., Daniel-Ivad P., Ryan K. S., Biosynthesis of the N-N-bond-containing compound l-alanosine. Angew. Chem. Int. Ed. 59, 3881–3885 (2020). [DOI] [PubMed] [Google Scholar]
  • 27.Kai K., Ohnishi H., Shimatani M., Ishikawa S., Mori Y., Kiba A., Ohnishi K., Tabuchi M., Hikichi Y., Methyl 3-hydroxymyristate, a diffusible signal mediating phc quorum sensing in Ralstonia solanacearum. ChemBioChem 16, 2309–2318 (2015). [DOI] [PubMed] [Google Scholar]
  • 28.Wang D., Ding X., Rather P. N., Indole can act as an extracellular signal in Escherichia coli. J. Bacteriol. 183, 4210–4216 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Flavier A. B., Clough S. J., Schell M. A., Denny T. P., Identification of 3-hydroxypalmitic acid methyl ester as a novel autoregulator controlling virulence in Ralstonia solanacearum. Mol. Microbiol. 26, 251–259 (1997). [DOI] [PubMed] [Google Scholar]
  • 30.Dickey S. W., Cheung G. Y. C., Otto M., Different drugs for bad bugs: Antivirulence strategies in the age of antibiotic resistance. Nat. Rev. Drug Discov. 16, 457–471 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.LaSarre B., Federle M. J., Exploiting quorum sensing to confuse bacterial pathogens. Microbiol. Mol. Biol. Rev. 77, 73–111 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Dong Y.-H., Wang L.-H., Xu J.-L., Zhang H.-B., Zhang X.-F., Zhang L.-H., Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase. Nature 411, 813–817 (2001). [DOI] [PubMed] [Google Scholar]
  • 33.Commission Regulation EC No 889/2008 , Laying down detailed rules for the implementation of council regulation (EC) no 834/2007 on organic production and labelling of organic products with regard to organic production, labelling and control. Off. J. Eur. Communities: Legis L250, 1–84 (2008). [Google Scholar]
  • 34.Gasson M. J., Indicator technique for antimetabolic toxin production by phytopathogenic species of Pseudomonas. Appl. Environ. Microbiol. 39, 25–29 (1980). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Stachel S. E., An G., Flores C., Nester E. W., A Tn3 lacZ transposon for the random generation of b-galactosidase gene fusions: Application to the analysis of gene expression in Agrobacterium. EMBO J. 4, 891–898 (1985). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Arrebola E., Cazorla F. M., Codina J. C., Gutiérrez-Barranquero J. A., Pérez-García A., de Vicente A., Contribution of mangotoxin to the virulence and epiphytic fitness of Pseudomonas syringae pv. syringae. Int. Microbiol. 12, 87–95 (2009). [PubMed] [Google Scholar]
  • 37.Takenaka Y., Kiyosu T., Choi J.-C., Sakakura T., Yasuda H., Selective synthesis of N-alkyl hydroxylamines by hydrogenation of nitroalkanes using supported palladium catalysts. ChemSusChem 3, 1166–1168 (2010). [DOI] [PubMed] [Google Scholar]
  • 38.Cazorla F. M., Torés J. A., Olalla L., Pérez-García A., Farré J. M., de Vicente A., Bacterial apical necrosis of mango in southern Spain: A disease caused by Pseudomonas syringae pv. syringae. Phytopathology 88, 614–620 (1998). [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Materials and Methods

Figs. S1 to S13

Tables S1 to S6

References


Articles from Science Advances are provided here courtesy of American Association for the Advancement of Science

RESOURCES